This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Oncology Expert Insights

Welcome to the Expert Insights podcast and webinar series. Throughout this series, we will be evaluating the management of ovarian cancer within the UK and debating the relevance and implications of ‘hot topics’ in patient care. We will be sharing insights from key members of the ovarian cancer community with you, as we invite them to give their opinions on the latest developments in the changing treatment landscape.

Welcome to the Expert Insights podcast and webinar series. Throughout this series, we will be evaluating the management of ovarian cancer within the UK and debating the relevance and implications of ‘hot topics’ in patient care. We will be sharing insights from key members of the ovarian cancer community with you, as we invite them to give their opinions on the latest developments in the changing treatment landscape.

On-demand webinar: How is COVID-19 affecting the treatment and management of ovarian cancer?

Presentation Slide

How is COVID-19 affecting the treatment and management of ovarian cancer?

Video player requires JavaScript enabled. You can download this video here: https://videos.gskstatic.com/pharma/GSKpro/Uk/covid-19-oncology-webinar-1-recording-july-pi-update-uk.mp4

A panel of four experts in ovarian cancer discuss how the COVID-19 outbreak is affecting the management of ovarian cancer and treatment of their patients and further explore how to use the updated British Gynaecological Cancer Society (BGCS) guidelines appropriately in this climate.

Meet the panel

Professor Jonathan Ledermann

Jonathan Ledermann

Professor of Medical Oncology at University College London (UCL) Cancer Institute, Director of Cancer Research UK at UCL Cancer Trials Centre and Honorary Consultant in Medical Oncology UCL hospitals.

Doctor Rebecca Bowen

Rebecca Bowen

Consultant Medical Oncologist at the Royal United Hospitals Bath NHS Foundation trust and an honorary lecturer at the University of Bath.

Doctor Rebecca Bowen

Christina Fotopoulou

Consultant Gynaecological Oncologist at Queen Charlotte's and Chelsea Hospital and Professor of Practice (Gynaecological Oncology) at Imperial College London.

Professor Marcia Hall

Marcia Hall

Consultant Medical Oncologist at Mount Vernon Cancer Centre, Hillingdon Hospital, UK and Wexham Park Hospital, UK and Professor of Translational Oncology at Brunel University London.

Episode 1: How is COVID-19 affecting the treatment and management of ovarian cancer?

Presentation Slide

How is COVID-19 affecting the treatment and management of ovarian cancer?

Video player requires JavaScript enabled. You can download this video here: https://videos.gskstatic.com/pharma/GSKpro/Uk/mp4/covid-19-oncology-podcast-recording-episode-1.mp4

To download this podcast to your smartphone, please visit our mobile site.

A panel of four experts in ovarian cancer discuss how the COVID-19 outbreak is affecting the management of ovarian cancer and treatment of their patients and further explore how to use the updated British Gynaecological Cancer Society (BGCS) guidelines appropriately in this climate.

Meet the panel

Professor Jonathan Ledermann

Professor Jonathan Ledermann as Chair, Professor of Medical Oncology at University College London (UCL) Cancer Institute, Director of Cancer Research UK at UCL Cancer Trials Centre and Honorary Consultant in Medical Oncology UCL Hospitals.

Doctor Rebecca Bowen

Doctor Rebecca Bowen, Consultant Medical Oncologist at the Royal United Hospitals Bath NHS Foundation Trust and an Honorary Lecturer at the University of Bath.

Professor Marcia Hall

Professor Marcia Hall, Consultant Medical Oncologist at Mount Vernon Cancer Centre, Hillingdon Hospital, UK and Wexham Park Hospital, UK and Professor of Translational Oncology at Brunel University London.

Doctor Agnieszka Michael

Doctor Agnieszka Michael, Reader in Oncology and Consultant Medical Oncologist at the University of Surrey and Royal Surrey County Hospital.

 Stay up to date

Stay up to date

Sign up for a GSKpro account and be the first to know when the next podcast is available.

Sign up now

 Stay up to date

Stay up to date

Sign up for a GSKpro account and be the first to know when the next podcast is available.

Sign up now

 Stay up to date
 Stay up to date

Stay up to date

Sign up for a GSKpro account and be the first to know when the next podcast is available.

Sign up now

 Stay up to date

Stay up to date

Sign up for a GSKpro account and be the first to know when the next podcast is available.

Sign up now

ZEJULA is a registered trademark of the GlaxoSmithKline group of companies.

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/.
Adverse events should also be reported to GlaxoSmithKline UK on 0800 221 441.